NSAIDs Ibuprofen, Indometacin and Diclofenac do not interact with Farnesoid X Receptor
出版年份 2015 全文链接
标题
NSAIDs Ibuprofen, Indometacin and Diclofenac do not interact with Farnesoid X Receptor
作者
关键词
-
出版物
Scientific Reports
Volume 5, Issue 1, Pages -
出版商
Springer Nature
发表日期
2015-10-01
DOI
10.1038/srep14782
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Tissue-specific actions of FXR in metabolism and cancer
- (2015) Raffaella Maria Gadaleta et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Efficacy of Obeticholic Acid in Patients With Primary Biliary Cirrhosis and Inadequate Response to Ursodeoxycholic Acid
- (2015) Gideon M. Hirschfield et al. GASTROENTEROLOGY
- Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
- (2015) Brent A Neuschwander-Tetri et al. LANCET
- FXR antagonism of NSAIDs contributes to drug-induced liver injury identified by systems pharmacology approach
- (2015) Weiqiang Lu et al. Scientific Reports
- Beyond Bile Acids: Targeting Farnesoid X Receptor (FXR) with Natural and Synthetic Ligands
- (2014) Andrea Carotti et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Medicinal Chemistry and Pharmacological Effects of Farnesoid X Receptor (FXR) Antagonists
- (2014) Christina Lamers et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Extending the Structure–Activity Relationship of Anthranilic Acid Derivatives As Farnesoid X Receptor Modulators: Development of a Highly Potent Partial Farnesoid X Receptor Agonist
- (2014) Daniel Merk et al. JOURNAL OF MEDICINAL CHEMISTRY
- Beyond intestinal soap—bile acids in metabolic control
- (2014) Folkert Kuipers et al. Nature Reviews Endocrinology
- Characterizing ligands for farnesoid X receptor – availablein vitrotest systems for farnesoid X receptor modulator development
- (2013) Daniel Merk et al. Expert Opinion on Drug Discovery
- Biosynthesis and trafficking of the bile salt export pump, BSEP: Therapeutic implications of BSEP mutations
- (2013) Carol J. Soroka et al. MOLECULAR ASPECTS OF MEDICINE
- Investigation of imatinib and other approved drugs as starting points for antidiabetic drug discovery with FXR modulating activity
- (2012) Ramona Steri et al. BIOCHEMICAL PHARMACOLOGY
- Medicinal chemistry of farnesoid X receptor ligands: from agonists and antagonists to modulators
- (2012) Daniel Merk et al. Future Medicinal Chemistry
- Role of nuclear receptor SHP in metabolism and cancer
- (2010) Yuxia Zhang et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Discovery of novel and orally active FXR agonists for the potential treatment of dyslipidemia & diabetes
- (2010) Hans G.F. Richter et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Antidiabetic sulfonylureas modulate farnesoid X receptor activation and target gene transcription
- (2010) Ramona Steri et al. Future Medicinal Chemistry
- Identification of an N-oxide pyridine GW4064 analog as a potent FXR agonist
- (2009) Song Feng et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now